Justin Holko | Investor Relations |
Leonard Schleifer | Founder, President and Chief Executive Officer |
George Yancopoulos | Co-Founder, President and Chief Scientific Officer |
Marion McCourt | Senior Vice President and Head, Commercial |
Bob Landry | Executive Vice President and Chief Financial Officer |
Terence Flynn | Goldman Sachs |
Geoffrey Porges | SVB Leerink |
Leo Ai | Cowen |
Chris Raymond | Piper Sandler |
Robyn Karnauskas | Truist |
Geoff Meacham | Bank of America |
Ronny Gal | Bernstein |
Tim Anderson | Wolfe Research |
Yatin Suneja | Guggenheim Partners |
Alethia Young | Cantor |
Evan Seigerman | Credit Suisse |
Ladies and gentlemen, thank you for standing by and welcome to the Regeneron Pharmaceuticals Q2 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Thank you.
Justin Holko, I will now turn the call over to you.
Thank you, Stephanie.